Flexion Therapeutics to Report Second-Quarter 2017 Financial Results on August 8, 2017
August 01 2017 - 7:30AM
Flexion Therapeutics, Inc. (Nasdaq:FLXN) announced today that it
will host a conference call and webcast to provide an update on
business operations and report its second-quarter 2017 financial
results on Tuesday, August 8, 2017, at 4:30 p.m. ET.
The dial-in number for the conference call is (855) 770-0022 for
domestic participants and (908) 982-4677 for international
participants, with Conference ID #56227594. A live webcast of the
conference call can also be accessed through the "Investors" tab on
the Flexion Therapeutics website. A webcast replay will be
available online following the call.
About Flexion Therapeutics Flexion Therapeutics
is a specialty pharmaceutical company focused on the development
and commercialization of novel, local therapies for the treatment
of patients with musculoskeletal conditions, beginning with
osteoarthritis (OA), a type of degenerative arthritis. The
company’s core values are focus, ingenuity, tenacity, transparency
and fun. Flexion was named one of the Boston Business Journal’s
2017 Best Places to Work.
Contact:
Scott Young
Sr. Director, Corporate Communications & Investor Relations
Flexion Therapeutics, Inc.
T: 781-305-7194
syoung@flexiontherapeutics.com
Flexion Therapeutics (NASDAQ:FLXN)
Historical Stock Chart
From Aug 2024 to Sep 2024
Flexion Therapeutics (NASDAQ:FLXN)
Historical Stock Chart
From Sep 2023 to Sep 2024